Search PDMR transactions

Notifier
Name of person with notification obligation
Siavash Bashiri
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Siavash Bashiri
Position
Deputy CEO/Deputy Managing Director
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Xbrane Biopharma AB
Issuer´s LEI code
5493008DKD05APTKQO39
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Xbrane Biopharma AB SE0007789409 Disposal 5,000 Quantity 33.65 SEK 06/09/2023 NASDAQ STOCKHOLM AB
Share Xbrane Biopharma AB SE0007789409 Disposal 6,000 Quantity 32.45 SEK 07/09/2023 NASDAQ STOCKHOLM AB
Share Xbrane Biopharma AB SE0007789409 Disposal 5,890 Quantity 33.10 SEK 08/09/2023 NASDAQ STOCKHOLM AB
Share Xbrane Biopharma AB SE0007789409 Acquisition 1,417 Quantity 32.14340155 SEK 07/09/2023 NASDAQ STOCKHOLM AB
Share Xbrane Biopharma AB SE0007789409 Acquisition 621 Quantity 32.9942029 SEK 08/09/2023 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Xbrane Biopharma AB SE0007789409 Disposal 06/09/2023 NASDAQ STOCKHOLM AB 5,000 (Quantity) 33.65 SEK
Xbrane Biopharma AB SE0007789409 Disposal 07/09/2023 NASDAQ STOCKHOLM AB 6,000 (Quantity) 32.45 SEK
Xbrane Biopharma AB SE0007789409 Disposal 08/09/2023 NASDAQ STOCKHOLM AB 5,890 (Quantity) 33.10 SEK
Xbrane Biopharma AB SE0007789409 Acquisition 07/09/2023 NASDAQ STOCKHOLM AB 1,417 (Quantity) 32.14340155 SEK
Xbrane Biopharma AB SE0007789409 Acquisition 08/09/2023 NASDAQ STOCKHOLM AB 621 (Quantity) 32.9942029 SEK
<< Back